Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination of Lamivudine and Adefovir Dipivoxil for Treatment of Chronic Hepatitis B

NCT00023309 is registered in ClinicalTrials.gov with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) as lead sponsor.

NCT NCT00023309
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00023309 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination of Lamivudine and Adefovir Dipivoxil for Treatment of Chronic Hepatitis B
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2001
Completion date
August 31, 2013
Enrollment
41 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hbv (hepatitis b virus), hepatitis, hepatitis b